Trustiva™ is a licensed generic of Atripla® produced in an FDA-approved factory in India. It’s a three-drug combination antiretroviral (ARV) medicine used as a complete treatment regimen for HIV-1. It’s also the current WHO first-line treatment for HIV-1.
- Atripla® helps decrease the amount of HIV in your body so your immune system can work better.
- Atripla® lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life.
- Atripla® is indicated in adult and pediatric patients weighing at least 88 pounds (40 kg).